Menu
Back to User profile » Dr Juan Luis García Rivero
Papers published by Dr Juan Luis García Rivero:
FIDEPOC: Consensus on Inspiratory Flow and Lung Deposition as Key Decision Factors in COPD Inhaled Therapy
González-Torralba F, Baloira A, Abad A, Fuster A, García-Rivero JL, García-Sidro P, Márquez-Martín E, Palop M, Soler N, Velasco JL
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1005-1015
Published Date: 4 May 2022
Lung Deposition and Inspiratory Flow Rate in Patients with Chronic Obstructive Pulmonary Disease Using Different Inhalation Devices: A Systematic Literature Review and Expert Opinion [Corrigendum]
Baloira A, Abad A, Fuster A, García Rivero JL, García-Sidro P, Márquez-Martín E, Palop M, Soler N, Velasco JL, González-Torralba F
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2243-2244
Published Date: 3 August 2021
Lung Deposition and Inspiratory Flow Rate in Patients with Chronic Obstructive Pulmonary Disease Using Different Inhalation Devices: A Systematic Literature Review and Expert Opinion
Baloira A, Abad A, Fuster A, García Rivero JL, García-Sidro P, Márquez-Martín E, Palop M, Soler N, Velasco JL, González-Torralba F
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1021-1033
Published Date: 19 April 2021
Relationship Between Clinical Control, Respiratory Symptoms and Quality of Life for Patients with COPD
Alcazar-Navarrete B, Fuster A, García Sidro P, García Rivero JL, Abascal-Bolado B, Pallarés-Sanmartín A, Márquez E, Valido-Morales A, Boldova Loscertales A, Callejas-Gonzalez FJ, Palop M, Riesco JA, Golpe R, Soler-Cataluña JJ, Miravitlles M
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2683-2693
Published Date: 28 October 2020
Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with Spiromax® compared with Turbuhaler® in patients with moderate-to-severe chronic obstructive pulmonary disease in Spain
Darbà J, Ramírez G, García-Rivero JL, Mayoralas S, Pascual JF, Vargas D, Bijedic A
ClinicoEconomics and Outcomes Research 2017, 9:127-137
Published Date: 10 February 2017
A budget impact analysis of Spiromax® compared with Turbuhaler® for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions
Darbà J, Ramírez G, García-Rivero JL, Mayoralas-Alises S, Pascual JF, Roger A,Vargas D, Bijedic A
ClinicoEconomics and Outcomes Research 2016, 8:435-444
Published Date: 6 September 2016
A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD
Miravitlles M, Montero-Caballero J, Richard F, Santos S, Garcia-Rivero JL, Ortega F, Ribera X
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:407-415
Published Date: 26 February 2016